The COPD and asthma diagnostic market is growing due to increased smoking and technological advancements, with North America leading and Asia-Pacific showing high potential.
The COPD and asthma diagnostic & monitoring devices are used for the assessing, diagnosing and treating the patients of lung diseases such as COPD and asthma. As the lung function weakens with age, the respiratory system leads to several physiological, functional & immunological changes. The rising incidence of the chronic lung disease and asthma is pouring the growth of the market. In addition, these devices can be used in hospitals and at home. In addition, air pollution, climate change and allergies continue to drive market growth. Technologically advanced device development, regulatory approvals and product launches are driving market growth.
As per analysis, “COPD and Asthma Diagnostic and Monitoring Devices Market: Current Analysis and Forecast (2021-2027)” the key companies operating in the global COPD and asthma diagnostic & monitoring market include Nihon Kohden Corporation, Vyaire Medical Inc., Getinge AB, Becton Dickinson And Company, Masimo Corp., Dragerwerk AG & Co. KGAA, Smiths Medical, Invacare Corporation, Medtronic Plc., Koninklijke Philips N.V and among others.
In terms of therapeutic devices, COPD and asthma diagnostic & monitoring market can be segregated as mask, nebulizer, inhaler, ventilator and PAP (Positive Airway Pressure) device. In terms of monitoring devices, market can be segregated as capnographs, pulse oximeters and gas analysis. In terms of diagnostic devices, market can be segregated as peak flow meters, Polysomnography (PSG) devices, spirometers and other diagnostic devices. In terms of indication, market can be segregated as COPD and asthma. The asthma segment holds major share in global market owing to rise in prevalence of asthma patients. Additionally, in terms of end-user, market can be segregated as clinics, hospitals, homecare and others. The hospital segment is likely to exhibit considerable growth rate due to growth in technological upgradation in COPD & asthma devices during the forecast period.
Growth in population of active smokers, followed by portability of the drug delivery devices, daily exposure to environmental pollution, high prevalence of tobacco smoking, increase in lifestyle habits such as smoking & consumption of alcohol, growth in number of surgeries and increase in population susceptible to indoor air pollutants are some major factors, which are responsible for growth of the COPD and asthma diagnostic & monitoring market. Apart from this, strict regulatory procedures and high price of devices are some major factors, which are responsible for growth of the market.
Based on regional analysis, the North-America is the leading region in global COPD and asthma diagnostic & monitoring market owing to rise in prevalence of respiratory diseases as consequence of unhealthy lifestyles coupled with high stress levels across the region. The Asia-Pacific and Europe regions are predicted to witness higher growth rate due to rise in awareness regarding COPD & asthma devices over the forecast period. It is expected that future of the global COPD and asthma diagnostic & monitoring market will be optimistic on account of growth in geriatric population and incorporation of novel reimbursement models for respiratory & monitoring solution procedures during the forecast period.
For More Information, refer to below link:-
Global COPD and Asthma Diagnostic and Monitoring Market
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
Support@kenresearch.com
+91-9015378249
The article discusses the growth of the COPD and asthma diagnostic and monitoring market driven by the increase in active smokers.
Key factors include rising smoker population, technological advancements, and increased air pollution.
North America is leading, with Asia-Pacific and Europe expected to witness significant growth.
Explore more articles in the Research Reports category
